Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

The Japanese drugmaker said that Kim, president of its U.S. business unit, will succeed Chief Executive Christophe Weber, who ...

The partnership was formalized through signing of a Memorandum of Understanding (MOU) in the presence of Dr Ahmed Afifi, CEO ...

The Mumbai-headquartered pharma company report a 11% increase in net profit for three months ended December 2024, rising to ...

Sanofi said it will repurchase €5 billion ($5.2 billion) of stock and grow profits faster this year as the drugmaker pivots ...

Julie Kim, 54, has been running Takeda’s U.S. operations since 2022 and will assume the role of CEO in June next year, ...